Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kimmie McLaurin
Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants
PharmacoEconomics - Open
Health Policy
Pharmacology
Related publications
Respiratory Syncytial Virus (RSV) Immune Globulin and Palivizumab for Prevention of RSV Infection
American Journal of Health-System Pharmacy
Medicine
Health Policy
Pharmacology
Pharmacy
Hospital Admission of High Risk Infants for Respiratory Syncytial Virus Infection: Implications for Palivizumab Prophylaxis
Archives of Disease in Childhood: Fetal and Neonatal Edition
Pediatrics
Gynecology
Perinatology
Obstetrics
Medicine
Child Health
Correction To: Cost-Effectiveness of Rule-Based Immunoprophylaxis Against Respiratory Syncytial Virus Infections in Preterm Infants
European Journal of Pediatrics
Child Health
Pediatrics
Perinatology
Appropriateness of Age Thresholds for Respiratory Syncytial Virus Immunoprophylaxis in Moderate-Preterm Infants
JAMA Pediatrics
Child Health
Pediatrics
Perinatology
The Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus-Associated Hospitalizations in Infants With Congenital Diaphragmatic Hernia
Pediatrics and Neonatology
Child Health
Pediatrics
Perinatology
Chronologic Age at Hospitalization for Respiratory Syncytial Virus Among Preterm and Term Infants in the United States
Infectious Diseases and Therapy
Infectious Diseases
Microbiology
Viral Load in Respiratory Syncytial Virus Infected Premature Newborns Under Prophylaxis With Palivizumab
Virology: Research and Reviews
4cps-069 Evaluation of Palivizumab as Prophylaxis Against Respiratory Syncytial Virus Infection
770 Pathogenesis of Respiratory Syncytial (Rs) Virus Bronchiolitis in Infants
Pediatric Research
Child Health
Pediatrics
Perinatology